0001564590-21-047618 | 10-Q | XBRL Viewer

Print Document View Excel Document

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jul. 31, 2021	Aug. 31, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 31, 2021
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Registrant Name	Couchbase, Inc.
Entity Central Index Key	0001845022
Current Fiscal Year End Date	--01-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity File Number	001-40601
Entity Tax Identification Number	26-3576987
Entity Address, Address Line One	3250 Olcott Street
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	650
Local Phone Number	417-7500
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common stock, par value $0.00001 per share
Trading Symbol	BASE
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		43,342,865

Condensed Consolidated Balance Sheets (unaudited) - USD ($)	Jul. 31, 2021	Jan. 31, 2021
Current assets
Cash and cash equivalents	$ 239,246,000	$ 37,297,000
Short-term investments	14,321,000	19,546,000
Accounts receivable, net	20,183,000	35,897,000
Deferred commissions	8,645,000	8,353,000
Prepaid expenses and other current assets	8,099,000	2,449,000
Total current assets	290,494,000	103,542,000
Property and equipment, net	5,578,000	6,506,000
Deferred commissions, noncurrent	5,394,000	4,941,000
Other assets	1,316,000	2,199,000
Total assets	302,782,000	117,188,000
Current liabilities
Accounts payable	7,153,000	2,428,000
Accrued compensation and benefits	9,020,000	9,110,000
Other accrued liabilities	3,575,000	4,154,000
Deferred revenue	48,980,000	57,168,000
Total current liabilities	68,728,000	72,860,000
Long-term debt	24,963,000	24,948,000
Deferred revenue, noncurrent	5,356,000	4,542,000
Other liabilities	1,312,000	1,358,000
Total liabilities	100,359,000	103,708,000
Commitments and contingencies (Note 8)
Redeemable convertible preferred stock, $0.00001 par value; 0 shares and 26,070,258 shares authorized as of July 31, 2021 and January 31, 2021, respectively; 0 shares and 26,070,213 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively; aggregate liquidation preference of $314,829 as of January 31, 2021		259,822,000
Stockholders’ equity (deficit)
Preferred stock, $0.00001 par value; 200,000,000 and 0 shares authorized as of July 31, 2021 and January 31, 2021, respectively; 0 shares issued outstanding as of July 31, 2021 and January 31, 2021, respectively
Additional paid-in capital	515,245,000	37,410,000
Accumulated other comprehensive income	0	1,000
Accumulated deficit	(312,822,000)	(283,753,000)
Total stockholders’ equity (deficit)	202,423,000	(246,342,000)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 302,782,000	$ 117,188,000

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Statement Of Financial Position [Abstract]
Redeemable convertible preferred stock , par value	$ 0.00001	$ 0.00001
Redeemable convertible preferred stock, shares authorized	0	26,070,258
Redeemable convertible preferred stock, shares issued	0	26,070,213
Redeemable convertible preferred stock, shares outstanding	0	26,070,213
Redeemable convertible preferred stock, liquidation preference		$ 314,829
Preferred Stock, par value	$ 0.00001	$ 0.00001
Preferred Stock, shares authorized	200,000,000	0
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value	$ 0.00001	$ 0.00001
Common Stock, shares authorized	1,000,000,000	43,200,000
Common Stock, shares issued	43,282,941	6,199,305
Common Stock, shares outstanding	43,282,941	6,199,305

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Revenue:
Total revenue	$ 29,699	$ 25,160	$ 57,654	$ 48,205
Cost of revenue:
Total cost of revenue	3,525	2,683	6,917	5,360
Gross profit	26,174	22,477	50,737	42,845
Operating expenses:
Research and development	12,623	9,237	25,164	18,279
Sales and marketing	22,263	16,475	42,897	33,702
General and administrative	5,278	3,468	10,775	6,861
Total operating expenses	40,164	29,180	78,836	58,842
Loss from operations	(13,990)	(6,703)	(28,099)	(15,997)
Interest expense	(252)	(2,495)	(497)	(4,016)
Other income (expense), net	(77)	614	7	307
Loss before income taxes	(14,319)	(8,584)	(28,589)	(19,706)
Provision for income taxes	151	254	480	482
Net loss	(14,470)	(8,838)	(29,069)	(20,188)
Cumulative dividends on Series G redeemable convertible preferred stock	(1,438)	(1,150)	(2,917)	(1,150)
Net loss attributable to common stockholders	$ (15,908)	$ (9,988)	$ (31,986)	$ (21,338)
Net loss per share attributable to common stockholders, basic and diluted	$ (1.76)	$ (1.76)	$ (4.16)	$ (3.77)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	9,045	5,662	7,696	5,660
License
Revenue:
Total revenue	$ 4,416	$ 3,010	$ 8,694	$ 5,540
Support and Other
Revenue:
Total revenue	23,613	20,627	45,800	39,269
Cost of revenue:
Total cost of revenue	2,072	1,276	4,124	2,273
Total Subscription Revenue
Revenue:
Total revenue	28,029	23,637	54,494	44,809
Services
Revenue:
Total revenue	1,670	1,523	3,160	3,396
Cost of revenue:
Total cost of revenue	$ 1,453	$ 1,407	$ 2,793	$ 3,087

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (14,470)	$ (8,838)	$ (29,069)	$ (20,188)
Other comprehensive income (loss):
Net unrealized gains (losses) on investments, net of tax	1		(1)
Total comprehensive loss	$ (14,469)	$ (8,838)	$ (29,070)	$ (20,188)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Jan. 31, 2020	$ (213,216)			$ 30,554		$ (243,770)
Beginning balance, Shares at Jan. 31, 2020		18,901,887
Beginning balance at Jan. 31, 2020		$ 155,506
Beginning balance, Shares at Jan. 31, 2020			5,646,238
Issuance of common stock upon exercise of stock options	144			144
Issuance of common stock upon exercise of stock, Shares			26,249
Issuance of Series G redeemable convertible preferred stock, net of issuance costs		$ 104,316
Issuance of Series G redeemable convertible preferred stock, net of issuance costs, Shares		7,168,326
Stock-based compensation	2,207			2,207
Net loss	(20,188)					(20,188)
Ending balance at Jul. 31, 2020	(231,053)			32,905		(263,958)
Ending balance, Shares at Jul. 31, 2020		26,070,213
Ending balance at Jul. 31, 2020		$ 259,822
Ending balance, Shares at Jul. 31, 2020			5,672,487
Beginning balance at Apr. 30, 2020	(223,639)			31,481		(255,120)
Beginning balance, Shares at Apr. 30, 2020		18,901,887
Beginning balance at Apr. 30, 2020		$ 155,506
Beginning balance, Shares at Apr. 30, 2020			5,659,677
Issuance of common stock upon exercise of stock options	58			58
Issuance of common stock upon exercise of stock, Shares			12,810
Issuance of Series G redeemable convertible preferred stock, net of issuance costs		$ 104,316
Issuance of Series G redeemable convertible preferred stock, net of issuance costs, Shares		7,168,326
Stock-based compensation	1,366			1,366
Net loss	(8,838)					(8,838)
Ending balance at Jul. 31, 2020	(231,053)			32,905		(263,958)
Ending balance, Shares at Jul. 31, 2020		26,070,213
Ending balance at Jul. 31, 2020		$ 259,822
Ending balance, Shares at Jul. 31, 2020			5,672,487
Beginning balance at Jan. 31, 2021	$ (246,342)			37,410	$ 1	(283,753)
Beginning balance, Shares at Jan. 31, 2021	26,070,213	26,070,213
Beginning balance at Jan. 31, 2021		$ 259,822
Beginning balance, Shares at Jan. 31, 2021			6,199,305
Issuance of common stock upon exercise of stock options	$ 4,288			4,288
Issuance of common stock upon exercise of stock, Shares	759,081		783,052
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ 259,822	$ (259,822)		259,822
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares		(26,070,213)	26,710,600
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs	209,924			209,924
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs, Shares			9,589,999
Settlement of fractional shares to be paid in cash	(9)			(9)
Settlement of fractional shares to be paid in cash, Shares			(15)
Stock-based compensation	3,810			3,810
Net unrealized gains (losses) on investments	(1)				(1)
Net loss	(29,069)					(29,069)
Ending balance at Jul. 31, 2021	$ 202,423			515,245		(312,822)
Ending balance, Shares at Jul. 31, 2021	0
Ending balance, Shares at Jul. 31, 2021			43,282,941
Beginning balance at Apr. 30, 2021	$ (257,667)			40,686	(1)	(298,352)
Beginning balance, Shares at Apr. 30, 2021		26,070,213
Beginning balance at Apr. 30, 2021		$ 259,822
Beginning balance, Shares at Apr. 30, 2021			6,460,868
Issuance of common stock upon exercise of stock options	2,841			2,841
Issuance of common stock upon exercise of stock, Shares			521,489
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	259,822	$ (259,822)		259,822
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares		(26,070,213)	26,710,600
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs	209,924			209,924
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other issuance costs, Shares			9,589,999
Settlement of fractional shares to be paid in cash	(9)			(9)
Settlement of fractional shares to be paid in cash, Shares			(15)
Stock-based compensation	1,981			1,981
Net unrealized gains (losses) on investments	1				$ 1
Net loss	(14,470)					(14,470)
Ending balance at Jul. 31, 2021	$ 202,423			$ 515,245		$ (312,822)
Ending balance, Shares at Jul. 31, 2021	0
Ending balance, Shares at Jul. 31, 2021			43,282,941

Condensed Consolidated Statements of Cash Flows (unaudited) $ in Thousands	6 Months Ended
	Jul. 31, 2021 USD ($)	Jul. 31, 2020 USD ($)
Cash flows from operating activities
Net loss	$ (29,069)	$ (20,188)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,406	607
Amortization of debt issuance costs	15	460
Debt prepayment costs		375
Stock-based compensation	3,810	2,207
Amortization of deferred commissions	6,326	4,505
Foreign currency transaction (gains) losses	5	(279)
Other	68	45
Changes in operating assets and liabilities
Accounts receivable	15,845	13,014
Deferred commissions	(7,071)	(4,758)
Prepaid expenses and other assets	(5,848)	(364)
Accounts payable	4,553	462
Accrued compensation and benefits	(91)	(1,244)
Other accrued liabilities	(1,749)	(794)
Deferred revenue	(7,375)	(13,514)
Net cash used in operating activities	(19,175)	(19,466)
Cash flows from investing activities
Purchases of short-term investments	(7,133)
Maturities of short-term investments	12,285
Purchases of property and equipment	(250)	(2,626)
Net cash provided by (used in) investing activities	4,902	(2,626)
Cash flows from financing activities
Payments of debt		(31,777)
Proceeds from issuance of debt, net of issuance costs		6,402
Proceeds from issuance of Series G redeemable convertible preferred stock, net of issuance costs		104,316
Proceeds from exercise of stock options	4,288	144
Proceeds from initial public offering, net of underwriting discounts and commissions	214,854
Payments of deferred offering costs	(2,795)
Net cash provided by financing activities	216,347	79,085
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(125)	24
Net increase in cash, cash equivalents and restricted cash	201,949	57,017
Cash, cash equivalents and restricted cash
Beginning of period	37,840	18,767
End of period	239,789	75,784
Cash and cash equivalents	239,246	75,241
Restricted cash included in other assets	543	543
Supplemental disclosures of cash activities
Cash paid for income taxes	442	349
Cash paid for interest	495	2,494
Non-cash investing and financing activities:
Change in purchases of property and equipment included in accounts payable and other accrued liabilities	230	$ (533)
Change in deferred offering costs included in accounts payable and other accrued liabilities	1,051
Conversion of redeemable convertible preferred stock to common stock	$ 259,822

Description of Business

6 Months Ended

Jul. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of Business

1. Description of Business

Couchbase, Inc. (“Couchbase” or the “Company”) provides an enterprise-class, multi-cloud NoSQL database architected on top of an open source foundation. Couchbase was incorporated in the State of Delaware in 2008 and is headquartered in Santa Clara, California. In these notes to the unaudited condensed consolidated financial statements, the “Company,” “Couchbase” “we,” “us,” and “our” refers to Couchbase, Inc. and its subsidiaries on a consolidated basis.

Basis of Presentation and Summary of Significant Accounting Policies

6 Months Ended

Jul. 31, 2021

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission, (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2021, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three and six months ended July 31, 2021, are not necessarily indicative of the results to be expected for the year ending January 31, 2022, or for any other interim period or for any other future year.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended January 31, 2021, included in the Company’s final prospectus filed with the SEC pursuant to Rule 424(b)(4) on July 22, 2021 (Final Prospectus).

Initial Public Offering

In July 2021, the Company completed its initial public offering (“IPO”), for the sale and issuance of 9,589,999 shares of its common stock at $24.00 per share, which included 1,250,869 shares issued pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received net proceeds of $214.9 million, after deducting underwriters’ discounts and commissions and before consideration of other issuance costs. In connection with the IPO, all 26,710,600 shares of outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of common stock.

Prior to the IPO, all deferred offering costs were capitalized in other noncurrent assets on the condensed consolidated balance sheets. Deferred offering costs of $4.9 million, primarily consisting of accounting, legal, and other fees related to the Company’s IPO, were offset against the IPO proceeds upon the closing of the Company’s IPO in July 2021. As of July 31, 2021 and January 31, 2021, unpaid deferred offering costs totaled $2.1 million and $1.1 million, respectively.

Reverse Stock Split

On June 30, 2021, the Company effected a 2.5-for-1 reverse stock split of its outstanding common stock, common stock warrants, preferred stock, and stock option awards. All issued and outstanding shares of common stock, common stock warrants, preferred stock, stock option awards and per share data have been adjusted in these condensed consolidated financial statements, on a retrospective basis, to reflect the reverse stock split for all periods presented. The par value of the common stock and preferred stock was not adjusted because of the reverse stock split.

Fiscal Year

The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices (“SSP”) for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, stock-based compensation, the determination of allowance for doubtful accounts and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable.

The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected.

COVID-19

While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.

Significant Accounting Policies

There have been no significant changes to the Company’s significant accounting policies disclosed in “Note 2 – Basis of Presentation and Summary of Significant Accounting Policies” of the Company’s Final Prospectus.

Recent Accounting Pronouncements

Accounting Pronouncements Not Yet Adopted

Under the JOBS Act, the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period.

In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), which requires lessees to record most leases on their balance sheets and disclosing key information about lease arrangements. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases. The ASU makes 16 technical corrections to the new lease standard and other accounting topics, alleviating unintended consequences from applying the new standard. It does not make any substantive changes to the core provisions or principles of the new standard. In July 2018, the FASB also issued ASU 2018-11, Leases (Topic 842): Targeted Improvements. The ASU provides (1) an optional transition method that entities can use when adopting the standard and (2) a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are met. In March 2019, the FASB also issued ASU 2019-01, Leases (Topic 842): Codification Improvements, which impacts transition disclosures related to the new guidance. The Company plans to adopt this guidance using a modified retrospective approach on February 1, 2022 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to

adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other —Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new guidance is effective for the Company beginning February 1, 2022. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in Topic 740 to reduce cost and complexity of its application. This new guidance is effective for the Company beginning February 1, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity’s own equity and modifies the guidance on diluted earnings per share calculations. The guidance is effective for the Company beginning February 1, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments

6 Months Ended

Jul. 31, 2021

Cash Cash Equivalents And Short Term Investments [Abstract]

Cash Equivalents and Short-Term Investments

3. Cash Equivalents and Short-Term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):

	As of July 31, 2021
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash Equivalents
Money market funds	$	235,045	$	—	$	—		$	235,045
Total cash equivalents		235,045		—		—			235,045
Short-Term Investments
Commercial paper		8,095		—		—			8,095
Corporate debt securities		6,227		—		(1	)		6,226
Total short-term investments		14,322		—		(1	)		14,321
Total	$	249,367	$	—	$	(1	)	$	249,366

	As of January 31, 2021
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash Equivalents
Money market funds	$	31,438	$	—	$	—		$	31,438
Total cash equivalents		31,438		—		—			31,438
Short-Term Investments
Commercial paper		12,290		—		—			12,290
Corporate debt securities		7,255		2		(1	)		7,256
Total short-term investments		19,545		2		(1	)		19,546
Total	$	50,983	$	2	$	(1	)	$	50,984

During the three and six months ended July 31, 2021 and 2020, the Company did not reclassify any amounts to earnings from accumulated other comprehensive income (loss) related to unrealized gains or losses in other income (expense), net in the condensed consolidated statements of operations.

As of July 31, 2021 and January 31, 2021, the Company’s short-term investments had a contractual maturity date of less than one year.

As of July 31, 2021, the Company had five short-term investments in an unrealized loss position. These short-term investments had an estimated fair value of $4.4 million and were not in a continuous unrealized loss position for more than twelve months. As of January 31, 2021, the Company had one short-term investment in an unrealized loss position. This short-term investment had an estimated fair value of $0.9 million and was not in a continuous unrealized loss position for more than twelve months. During the three and six months ended July 31, 2021, the Company had no other-than-temporary impairments of short-term investments.

Fair Value Measurements

6 Months Ended

Jul. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

4. Fair Value Measurements

The Company accounts for certain of its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows:

Level 1: Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts reflected on the condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short maturities of those instruments. The carrying value of long-term debt approximated fair value as of July 31, 2021, and January 31, 2021, based on the borrowing rates currently available to the Company with similar terms. The fair value of long-term debt is a Level 2 fair value measurement.

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):

	As of July 31, 2021
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	235,045	$	—	$	—	$	235,045
Total cash equivalents		235,045		—		—		235,045
Short-Term Investments
Commercial paper		—		8,095		—		8,095
Corporate debt securities		—		6,226		—		6,226
Total short-term investments		—		14,321		—		14,321
Total	$	235,045	$	14,321	$	—	$	249,366

	As of January 31, 2021
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	31,438	$	—	$	—	$	31,438
Total cash equivalents		31,438		—		—		31,438
Short-Term Investments
Commercial paper		—		12,290		—		12,290
Corporate debt securities		—		7,256		—		7,256
Total short-term investments		—		19,546		—		19,546
Total	$	31,438	$	19,546	$	—	$	50,984

The Company classifies its money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its commercial paper and corporate debt securities within Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded.

There were no transfers of financial assets into or out of Level 1, Level 2 or Level 3 during the periods presented.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Balance Sheet Components

6 Months Ended

Jul. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components

5. Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Prepaid expenses	$	5,919	$	803
Prepaid software		1,656		1,380
Other current assets		524		266
Total prepaid expenses and other current assets	$	8,099	$	2,449

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of July 31,			As of January 31,
	2021			2021
Computer equipment	$	3,584		$	3,304
Furniture and fixtures		412			408
Capitalized internal-use software		5,772			5,772
Leasehold improvements		1,582			1,387
Total gross property and equipment		11,350			10,871
Accumulated depreciation and amortization		(5,772	)		(4,365	)
Total property and equipment, net	$	5,578		$	6,506

Depreciation and amortization expense was $0.7 million and $0.4 million for the three months ended July 31, 2021 and 2020, respectively, and $1.4 million and $0.6 million for the six months ended July 31, 2021 and 2020, respectively.

Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Accrued bonus	$	4,182	$	4,149
Accrued commissions		2,481		2,364
Accrued payroll and benefits		2,357		2,597
Total accrued compensation and benefits	$	9,020	$	9,110

Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Accrued professional fees	$	1,384	$	1,925
Sales and value added tax payable		106		415
Income taxes payable		513		436
Accrued interest		-		95
Other		1,572		1,283
Total other accrued liabilities	$	3,575	$	4,154

Deferred Revenue and Remaining Performance Obligations

6 Months Ended

Jul. 31, 2021

Revenue From Contract With Customer [Abstract]

Deferred Revenue and Remaining Performance Obligations

6. Deferred Revenue and Remaining Performance Obligations

The following table presents the deferred revenue balances (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Deferred revenue, current	$	48,980	$	57,168
Deferred revenue, noncurrent		5,356		4,542
Total deferred revenue	$	54,336	$	61,710

Changes in the deferred revenue balances during the and six months ended July 31, 2021 and 2020 (unaudited) were as follows (in thousands):

	Six Months Ended July 31,
	2021			2020
Beginning balance	$	61,710		$	60,929
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year		(38,813	)		(39,997	)
Increases due to invoicing prior to satisfaction of performance obligations		31,439			26,483
Ending balance	$	54,336		$	47,415

Remaining performance obligations (“RPOs”) represent the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods.

As of July 31, 2021, the Company’s RPOs were $118.9 million. The Company expects to recognize revenue of $74.1 million of these remaining performance obligations over the next twelve months, with the remaining balances recognized thereafter.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045

+ Details

Debt

6 Months Ended

Jul. 31, 2021

Debt Disclosure [Abstract]

Debt

7. Debt

Debt is presented net of issuance costs on the condensed consolidated balance sheets as follows (in thousands)

	As of July 31,			As of January 31,
	2021			2021
Principal outstanding	$	25,000		$	25,000
Unamortized discount and debt issuance costs		(37	)		(52	)
Long-term debt	$	24,963		$	24,948

Interest expense on the Company’s borrowings was $0.3 million and $2.5 million for the three months ended July 31, 2021 and 2020, respectively, and $0.5 million and $4.0 million for the six months ended July 31, 2021 and 2020, respectively. The effective interest rate was 3.9% and 6.5% for the three months ended July 31, 2021 and 2020, respectively, and 3.9% and 8.9% for the six months ended July 31, 2021 and 2020, respectively.

Term Loan

In August 2018, the Company entered into an agreement for a term loan (the “Loan”) with Hercules Capital to borrow up to a maximum of $35.0 million over a period of three years with an original maturity date in September 2021. The interest on the Loan is the greater of (1) 10.75% plus the prime rate minus 5.5% and (2) 10.75%. Under the terms of the Loan, the Company pays interest monthly and the aggregate Loan principal balance is due on the maturity date. The Loan is secured by a subordinated security interest in substantially all the assets of the Company except intellectual property and contains certain covenants, including covenants which prohibit the Company from declaring or making cash dividends. The Loan permits voluntary prepayment on borrowings with a penalty ranging from 0.25% to 2.50% of the prepaid principal amount. Additionally, the Loan allows the lender to accelerate and demand for all or part of the outstanding borrowings together with a prepayment penalty in the event of default (as defined by the Loan agreement). The Company borrowed $14.7 million, net of issuance costs, under the Loan upon closing in August 2018.

In April 2019, the Company entered into an amendment to the Loan with Hercules Capital to increase the maximum Loan amount to $70.0 million and extending the maturity date. The Company borrowed $34.8 million, net of issuance costs, during the year ended January 31, 2020. Under the terms of the amended Loan, the Company continued to pay interest at the same rate monthly with the aggregate principal balance repayment date being extended to May 2023. The amended Loan was also subject to a 3.75% end-of-term charge on the aggregate borrowings, payable upon maturity. The amendment also added certain financial covenants, including covenants related to achieving a target annual recurring revenue, that if not met by June 2022, could trigger early repayment in June

2022, and a target annual recurring revenue leverage ratio, that if not met, would limit the additional amount of borrowings under the Loan.

In June 2020, the Company paid off $25.0 million of the Loan and entered into an amendment to the Loan with Hercules Capital, which reduced the maximum borrowings under the Loan from $70.0 million to $25.0 million and extended the Loan maturity date to June 2024. Additionally, this amendment required the Company to make a prepayment charge equal to $0.4 million upon the effective date of the agreement. Accordingly, the Company paid a prepayment penalty of $0.4 million and an end-of-term charge of $0.9 million in accordance with the terms of the Loan which was recorded as interest expense in the condensed consolidated statement of operations.

In January 2021, the Company terminated the Loan and paid off the $25.0 million remaining outstanding balance of the Loan together with a prepayment penalty of $0.6 million and an end-of-term charge of $0.9 million in accordance with the terms of the Loan, which was recorded as interest expense in the condensed consolidated statement of operations. The Company wrote off the remaining unamortized debt discounts and issuance costs to interest expense upon the termination of the Loan with Hercules in January 2021.

In connection with the amendment in April 2019, the Company also issued warrants to purchase shares of the Company’s common stock at $7.48 per share, exercisable over 10 years. The warrants were issuable at 2.25% of the aggregate amount of the borrowings drawn concurrently and after the amendment. The Company issued warrants to purchase 75,250 shares of the Company’s common stock on $25.0 million that was borrowed concurrently with the execution of the amendment and warrants to purchase an additional 30,100 shares of the Company’s common stock upon borrowings of an additional $10.0 million in December 2019. The warrants were recorded at fair value using the Black-Scholes option pricing model. The fair value of the warrants was recorded to equity and as a debt discount that was amortized to interest over the term of the loan. The total fair value of the common stock warrants was $0.4 million. As of July 31, 2021, all warrants were outstanding and exercisable.

Credit Facility

In November 2017, the Company entered into a line of credit agreement with Silicon Valley Bank, or Credit Facility, providing the Company the ability to borrow up to $10.0 million from a revolving line of credit with an original maturity date in November 2018. Borrowings under the line of credit bear interest at a floating per annum rate equal to one half of one percentage point (0.50%) above the prime rate, which interest shall be payable monthly. The line of credit is secured with a pledge on substantially all the assets of the Company, except any intellectual property and is subject to a minimum revenue covenant.

In November 2018, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $15.0 million and extend the maturity date to November 2019.

In April 2019, an amendment was entered into with the Silicon Valley Bank to decrease the line of credit to $10.0 million. In October 2019, an amendment was entered into with Silicon Valley Bank to extend the maturity of the line of credit to November 2020. There were no borrowings against the line of credit as of January 31, 2020.

In November 2020, the Company entered into an amendment with Silicon Valley Bank to extend the maturity of the line of credit to February 2021. In January 2021, the Company entered into an amendment with Silicon Valley Bank to increase the line of credit limit to $40.0 million and extend the maturity date to January 2024. Upon the execution of this amendment, the Company borrowed $25.0 million from the line of credit. The outstanding principal balance is due at maturity with interest payable monthly. The line of credit bears a variable annual interest rate of the prime rate plus 0.5%. The Company is required to pay a fee equal to 0.25% per annum on the unused portion of the line of credit. The Company is also subject to a termination fee ranging from 0.5% to 1.0% of the line of credit if the Company terminates the agreement prior to the maturity date. The amendment also added certain financial covenants, including covenants related to certain financial metrics, that if not met, would limit the amount of additional borrowings under the line of credit. As of July 31, 2021, $15.0 million was available for borrowing under the line of credit.

The amended line of credit agreement requires the company to maintain an adjusted quick ratio (as defined by the agreement) of at least 1.15 to 1.0. The line of credit agreement also contains certain customary affirmative and negative covenants as well as customary events of default, subject to certain exceptions, including restrictions on the Company’s ability to, among other things, incur debt and liens, maintain collateral accounts, undergo fundamental changes including mergers or consolidations, dispose assets including selling, transferring or assigning assets, pay dividends or other distributions or make or permit payments on any subordinated debt. The Company was in compliance with the financial covenants under the line of credit as of July 31, 2021.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Commitments and Contingencies

6 Months Ended

Jul. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

8. Commitments and Contingencies

Operating Leases

The Company leases facilities for office space under non-cancelable operating leases with various expiration dates through March 2025.

Rent expense was $0.7 million and $0.7 million for the three months ended July 31, 2021 and 2020, respectively, and $1.3 million and $1.4 million for the six months ended July 31, 2021 and 2020, respectively.

Other Contractual Commitments

Other contractual commitments relate to third-party cloud infrastructure agreements and subscription arrangements.

In July 2021, the Company negotiated a noncancelable arrangement with a cloud hosting service provider. Under the arrangement, the Company committed to spend an aggregate of at least $10.0 million between August 2021 and August 2024, with a minimum amount of approximately $3.0 million in each of the first two years and $4.0 million in the third year on services with this vendor.

As of July 31, 2021, except for the arrangement noted above, there were no other material changes to the Company’s other contractual commitments since January 31, 2021.

Legal Matters

From time to time, the Company may be a party to various legal matters, threatened claims, or proceedings in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with its legal counsel, the need to record a liability for litigation and contingencies. Legal accruals are recorded when and if it is determined that a loss related to a certain matter is both probable and reasonably estimable.

Indemnification

The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claims brought by any third party against such indemnified party with respect to licensed technology. The term of these indemnification agreements is generally perpetual any time after the execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future but have not yet been made. To date, the Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements.

The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. No liability associated with such indemnifications has been recorded as of July 31, 2021, or January 31, 2021.

Retirement Plan

6 Months Ended

Jul. 31, 2021

Compensation And Retirement Disclosure [Abstract]

Retirement Plan

9. Retirement Plan

The Company sponsors a defined contribution savings plan under Section 401(k) of the Internal Revenue Code of 1986, as amended, covering substantially all full-time U.S. employees. Each eligible employee may contribute to the 401(k) plan in accordance with the plan terms. The Company matches its employee contributions to the 401(k) plan. The total matching contributions were $0.1 million and less than $0.1 million for the three months ended July 31, 2021 and 2020, respectively, and $0.2 million and $0.2 million for the six months ended July 31, 2021 and 2020, respectively.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Stockholders' Equity (Deficit) and Employee Incentive Plans

6 Months Ended

Jul. 31, 2021

Equity And Compensation Related Costs Share Based Payments [Abstract]

Stockholders' Equity (Deficit) and Employee Incentive Plans

10. Stockholders’ Equity (Deficit) and Employee Incentive Plans

Redeemable Convertible Preferred Stock

Upon the closing of the Company’s IPO, all 26,710,600 shares of redeemable convertible preferred stock were automatically converted into shares of common stock, which includes an additional 640,387 shares of redeemable convertible preferred stock. The additional shares of redeemable convertible preferred stock consisted of 162,032 shares for the Series E conversion feature and 478,355 shares for the Series G dividends. The carrying value of $259.8 million was reclassified into common stock and additional paid-in-capital. As of July 31, 2021, there were no shares of redeemable convertible preferred stock issued and outstanding.

In connection with the IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 200,000,000 shares of undesignated preferred stock with a par value of $0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors.

Common Stock

The Company’s Amended and Restated Certificate of Incorporation authorized the Company to issue 1,000,000,000 and 43,200,000 shares of common stock at a par value of $0.00001 as of July 31, 2021 and January 31, 2021, respectively. As of July 31,

2021 and January 31, 2021, approximately 43,282,941 and 6,199,305 shares of common stock were issued and outstanding, respectively.

Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. As of July 31, 2021 and January 31, 2021, no dividends had been declared.

As of July 31, 2021, the Company has reserved common stock for future issuance, as follows:

	Number of Shares
Stock options outstanding		9,908,576
Common stock warrants		105,350
Reserved for future grant of stock options		4,120,000
Total		14,133,926

Stock Plans

The Company has three equity incentive plans: the 2008 Equity Incentive Plan (the “2008 Plan”) 2018 Equity Incentive Plan (the “2018 Plan”) and the 2021 Equity Incentive Plan (the “2021 Plan”), collectively (the “Stock Plans”). In connection with the Company’s IPO in July 2021, the 2008 Plan and the 2018 Plan were terminated and replaced by the 2021 Plan and all shares that remained available for issuance under the 2018 Plan at that time were reserved for issuance under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will be increased by any shares of common stock subject to awards outstanding under the 2018 Plan that expire or otherwise terminate without having been exercised or issued in full, are tendered to or withheld by the Company for payment of an exercise price or for satisfying tax withholding obligations or are forfeited to or repurchased by the Company due to failure to vest.

The Company has issued stock options to employees, directors, consultants, and advisors pursuant to the 2018 Plan. Through July 31, 2021, the Company has granted no equity awards pursuant to the 2021 Plan.

Options granted under the 2021 Plan may be stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Stock option grants may be either Incentive Stock Options (“ISO”) or Non-Qualified Stock Options (“NSO”). ISO may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, consultants, and nonemployee directors. Employee stock options are granted with an exercise price no less than the fair value of the underlying common stock on the grant date. Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter.

As of July 31, 2021, there were 4.1 million shares available for grant under the 2021 Plan. The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding Shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year.

Stock option activity and activity regarding shares available for grant under the Stock Plans for six months ended July 31, 2021 are as follows (aggregate intrinsic value in thousands):

				Options Outstanding
	Shares Available for Grant			Number of Options			Weighted- Average Exercise Price		Weighted- Average Contractual Term		Aggregate Intrinsic Value
Balances as of January 31, 2021		253,958			8,912,477		$	6.42		6.49	$	38,582
Additional shares reserved		5,604,548			—
Options exercised		—			(759,081	)	$	5.48
Options granted		(1,948,563	)		1,948,563		$	22.49
Options cancelled		210,057			(210,057	)	$	8.48
Balances as of July 31, 2021		4,120,000			9,891,902		$	9.61		6.94	$	203,235
Options vested and expected to vest as of July 31, 2021					9,891,902		$	9.61		6.94	$	203,235
Options vested and exercisable as of July 31, 2021					5,804,191		$	5.93		5.51	$	140,607

Stock options granted during the three months ended July 31, 2021 and 2020 had a weighted-average grant-date fair value of $11.31 and $2.99, respectively. The aggregate intrinsic value of options exercised during the three months ended July 31, 2021 and 2020 was $10.6 million and less than $0.1 million, respectively.

Stock options granted during the six months ended July 31, 2021 and 2020 had a weighted-average grant-date fair value of $9.30 and $2.99, respectively. The aggregate intrinsic value of options exercised during the six months ended July 31, 2021 and 2020 was $14.4 million and $0.1 million, respectively.

Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock.

The fair value of employee stock options was estimated using the following weighted-average assumptions:

	Three Months Ended July 31,						Six Months Ended July 31,
	2021			2020			2021			2020
Stock Option Plans:
Expected term (in years)		6.1			6.1			6.1			6.1
Expected volatility		42.4	%		39.9	%		42.0	%		39.9	%
Risk-free interest rate		1.0	%		0.4	%		1.0	%		0.4	%
Dividend yield		—			—			—			—

Expected term—The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding and is calculated using the simplified method, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. The simplified method calculates the expected term as the midpoint between the vesting date and the contractual expiration date of the option.

Expected volatility—The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company does not have any trading history for the Company’s common stock.

Risk-free interest rate—The risk-free rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options.

Dividend yield—The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Fair value of underlying common stock— Prior to the Company’s initial public offering, the fair value was determined by the Board of Directors with input from management and contemporaneous independent third-party valuations. Subsequent to the IPO, the fair value of the Company’s common stock is based on the daily average selling price on the Nasdaq Global Select Market.

Stock-Based Compensation

Stock-based compensation expense was as follows (in thousands):

	Three Months Ended July 31,				Six Months Ended July 31,
	2021		2020		2021		2020
Cost of revenue—subscription	$	30	$	19	$	57	$	34
Cost of revenue—services		24		17		46		27
Research and development		569		394		1,139		640
Sales and marketing		688		412		1,229		676
General and administrative		670		524		1,339		830
Total stock-based compensation expense	$	1,981	$	1,366	$	3,810	$	2,207

Stock-based compensation expense related to options granted to nonemployees for the three and six months ended July 31, 2021 and 2020 was not material.

As of January 31, 2021 and July 31, 2021, there was $8.7 million and $22.4 million, respectively, of unrecognized stock-based compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 2.5 years and 2.8 years, respectively.

Employee Stock Purchase Plan

In July 2021, the Company established an Employee Stock Purchase Plan (“ESPP”) in which eligible employees may contribute up to 15% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of (1) the fair market value of a share of the Company’s common stock at the beginning of the offering period and (2) the fair market value of a share of the

Company’s common stock on the purchase date. A participant will be permitted to purchase a maximum of shares during each offering period. No participant may purchase more than 1,000 shares during any offering period. As of July 31, 2021, 830,000 shares were available for issuance and no shares of common stock were issued under the ESPP.

Except for the initial offering period, the 2021 ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering shall consist of four purchase periods with the first purchase period ending on March 20, 2022, and the final purchase period ending on September 20, 2023. For accounting purposes, the grant date of the first offering was subsequent to July 31, 2021.

Income Taxes

6 Months Ended

Jul. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

11. Income Taxes

Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and records a cumulative adjustment in such period.

The Company recorded income tax expense of $0.2 million and $0.3 million for the three months ended July 31, 2021 and 2020, respectively, and $0.5 million and $0.5 million for the six months ended July 31, 2021 and 2020, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, capitalized research and development, and other book versus tax differences was maintained.

The American Rescue Plan Act (ARPA) was signed into law on March 11, 2021. The ARPA did not have any impact on the Company’s provision for income taxes for the three and six months ended July 31, 2021.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Geographic Information

6 Months Ended

Jul. 31, 2021

Segment Reporting [Abstract]

Geographic Information

12. Geographic Information

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):

	Three Months Ended July 31,				Six Months Ended July 31,
	2021		2020		2021		2020
United States	$	18,336	$	16,149	$	36,383	$	31,366
International		11,363		9,011		21,271		16,839
Total	$	29,699	$	25,160	$	57,654	$	48,205

No individual foreign country contributed 10% or more of total revenue for the three and six months ended July 31, 2021 and 2020.

As of January 31, 2021 and July 31, 2021, substantially all of the Company’s long-lived assets were located in the United States.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Net Loss per Share

6 Months Ended

Jul. 31, 2021

Earnings Per Share [Abstract]

Net Loss per Share

13. Net Loss per Share

Basic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all years presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented.

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):

	Three Months Ended July 31,						Six Months Ended July 31,
	2021			2020			2021			2020
Numerator
Net loss	$	(14,470	)	$	(8,838	)	$	(29,069	)	$	(20,188	)
Cumulative dividends on Series G redeemable convertible preferred stock		(1,438	)		(1,150	)		(2,917	)		(1,150	)
Net loss attributable to common stockholders	$	(15,908	)	$	(9,988	)	$	(31,986	)	$	(21,338	)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted		9,045			5,662			7,696			5,660
Net loss per share attributable to common stockholders, basic and diluted	$	(1.76	)	$	(1.76	)	$	(4.16	)	$	(3.77	)

The following potentially dilutive securities were excluded from the computation of diluted net loss per share for the periods presented because the impact of including them would have been anti-dilutive (in thousands):

	As of July 31,
	2021		2020
Stock options		9,909		9,194
Redeemable convertible preferred stock (on an if-converted basis)		—		26,312
Common stock warrants		105		105
Total		10,014		35,611

Subsequent Events

6 Months Ended

Jul. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Events

Subsequent to July 31, 2021, the Company repaid the outstanding balance of its revolving line of credit of $25.0 million.

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission, (“SEC”), regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of January 31, 2021, and related disclosures, have been derived from the audited consolidated financial statements at that date but do not include all the information required by GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the Company’s annual consolidated financial statements and, in the opinion of management, reflect all adjustments (consisting of only normal recurring adjustments) that are necessary for the fair statement of the Company’s condensed consolidated financial information. The results of operations for the three and six months ended July 31, 2021, are not necessarily indicative of the results to be expected for the year ending January 31, 2022, or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended January 31, 2021, included in the Company’s final prospectus filed with the SEC pursuant to Rule 424(b)(4) on July 22, 2021 (Final Prospectus).
Initial Public Offering	Initial Public Offering In July 2021, the Company completed its initial public offering (“IPO”), for the sale and issuance of 9,589,999 shares of its common stock at $24.00 per share, which included 1,250,869 shares issued pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company received net proceeds of $214.9 million, after deducting underwriters’ discounts and commissions and before consideration of other issuance costs. In connection with the IPO, all 26,710,600 shares of outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of common stock. Prior to the IPO, all deferred offering costs were capitalized in other noncurrent assets on the condensed consolidated balance sheets. Deferred offering costs of $4.9 million, primarily consisting of accounting, legal, and other fees related to the Company’s IPO, were offset against the IPO proceeds upon the closing of the Company’s IPO in July 2021. As of July 31, 2021 and January 31, 2021, unpaid deferred offering costs totaled $2.1 million and $1.1 million, respectively.
Reverse Stock Split	Reverse Stock Split On June 30, 2021, the Company effected a 2.5-for-1 reverse stock split of its outstanding common stock, common stock warrants, preferred stock, and stock option awards. All issued and outstanding shares of common stock, common stock warrants, preferred stock, stock option awards and per share data have been adjusted in these condensed consolidated financial statements, on a retrospective basis, to reflect the reverse stock split for all periods presented. The par value of the common stock and preferred stock was not adjusted because of the reverse stock split.
Fiscal Year	Fiscal Year The Company’s fiscal year ends on January 31. Unless otherwise stated, references to year in these condensed consolidated financial statements relate to fiscal year rather than calendar year.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Couchbase, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts stated in the financial statements and accompanying notes. Such estimates include standalone selling prices (“SSP”) for each distinct performance obligation, capitalized internal-use software costs, expected period of benefit for deferred commissions, stock-based compensation, the determination of allowance for doubtful accounts and accounting for income taxes. The Company bases its estimates on historical experience and assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. Estimates and assumptions about future events and their effects, including the impact of the COVID-19 pandemic, cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the condensed consolidated financial statements as new events occur and additional information becomes known. To the extent the Company’s actual results differ materially from those estimates and assumptions, the Company’s future financial statements could be affected. COVID-19 While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment actions, it has already had an adverse effect on the global economy and the lasting effects of the pandemic continue to be unknown. The Company may experience customer losses, including due to bankruptcy or customers ceasing operations, which may result in delays in collections or an inability to collect accounts receivable from these customers. The impact of COVID-19 on the Company’s financial condition, results of operations, or liquidity continues to remain uncertain, and as of the date of issuance of these financial statements, the Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or an adjustment to the carrying value of the Company’s assets or liabilities. These estimates may change, as new events occur and additional information is obtained, which will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s financial statements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Pronouncements Not Yet Adopted Under the JOBS Act, the Company meets the definition of an emerging growth company and can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the Company is no longer an emerging growth company or until the Company affirmatively and irrevocably opts out of the extended transition period. In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), which requires lessees to record most leases on their balance sheets and disclosing key information about lease arrangements. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases. The ASU makes 16 technical corrections to the new lease standard and other accounting topics, alleviating unintended consequences from applying the new standard. It does not make any substantive changes to the core provisions or principles of the new standard. In July 2018, the FASB also issued ASU 2018-11, Leases (Topic 842): Targeted Improvements. The ASU provides (1) an optional transition method that entities can use when adopting the standard and (2) a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are met. In March 2019, the FASB also issued ASU 2019-01, Leases (Topic 842): Codification Improvements, which impacts transition disclosures related to the new guidance. The Company plans to adopt this guidance using a modified retrospective approach on February 1, 2022 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company plans to adopt this standard on February 1, 2023 and is currently evaluating the impact of the adoption on its condensed consolidated financial statements. In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other —Internal-Use Software, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new guidance is effective for the Company beginning February 1, 2022. The Company does not expect the adoption of this guidance to have a material impact on its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in Topic 740 to reduce cost and complexity of its application. This new guidance is effective for the Company beginning February 1, 2022. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity’s own equity and modifies the guidance on diluted earnings per share calculations. The guidance is effective for the Company beginning February 1, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on its condensed consolidated financial statements.

Cash Equivalents and Short-Term Investments (Tables)

6 Months Ended

Jul. 31, 2021

Cash Cash Equivalents And Short Term Investments [Abstract]

Summary of Cash Equivalents and Short-term Investments

The following tables summarize the Company’s cash equivalents and short-term investments (in thousands):

	As of July 31, 2021
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash Equivalents
Money market funds	$	235,045	$	—	$	—		$	235,045
Total cash equivalents		235,045		—		—			235,045
Short-Term Investments
Commercial paper		8,095		—		—			8,095
Corporate debt securities		6,227		—		(1	)		6,226
Total short-term investments		14,322		—		(1	)		14,321
Total	$	249,367	$	—	$	(1	)	$	249,366

	As of January 31, 2021
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Cash Equivalents
Money market funds	$	31,438	$	—	$	—		$	31,438
Total cash equivalents		31,438		—		—			31,438
Short-Term Investments
Commercial paper		12,290		—		—			12,290
Corporate debt securities		7,255		2		(1	)		7,256
Total short-term investments		19,545		2		(1	)		19,546
Total	$	50,983	$	2	$	(1	)	$	50,984

Fair Value Measurements (Tables)

6 Months Ended

Jul. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis (in thousands):

	As of July 31, 2021
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	235,045	$	—	$	—	$	235,045
Total cash equivalents		235,045		—		—		235,045
Short-Term Investments
Commercial paper		—		8,095		—		8,095
Corporate debt securities		—		6,226		—		6,226
Total short-term investments		—		14,321		—		14,321
Total	$	235,045	$	14,321	$	—	$	249,366

	As of January 31, 2021
	Level 1		Level 2		Level 3		Total
Cash Equivalents
Money market funds	$	31,438	$	—	$	—	$	31,438
Total cash equivalents		31,438		—		—		31,438
Short-Term Investments
Commercial paper		—		12,290		—		12,290
Corporate debt securities		—		7,256		—		7,256
Total short-term investments		—		19,546		—		19,546
Total	$	31,438	$	19,546	$	—	$	50,984

Balance Sheet Components (Tables)

6 Months Ended

Jul. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Prepaid expenses	$	5,919	$	803
Prepaid software		1,656		1,380
Other current assets		524		266
Total prepaid expenses and other current assets	$	8,099	$	2,449

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of July 31,			As of January 31,
	2021			2021
Computer equipment	$	3,584		$	3,304
Furniture and fixtures		412			408
Capitalized internal-use software		5,772			5,772
Leasehold improvements		1,582			1,387
Total gross property and equipment		11,350			10,871
Accumulated depreciation and amortization		(5,772	)		(4,365	)
Total property and equipment, net	$	5,578		$	6,506

Schedule of Accrued Compensation and Benefits

Accrued compensation and benefits consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Accrued bonus	$	4,182	$	4,149
Accrued commissions		2,481		2,364
Accrued payroll and benefits		2,357		2,597
Total accrued compensation and benefits	$	9,020	$	9,110

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Accrued professional fees	$	1,384	$	1,925
Sales and value added tax payable		106		415
Income taxes payable		513		436
Accrued interest		-		95
Other		1,572		1,283
Total other accrued liabilities	$	3,575	$	4,154

Deferred Revenue and Remaining Performance Obligations (Tables)

6 Months Ended

Jul. 31, 2021

Revenue From Contract With Customer [Abstract]

Schedule of Deferred Revenue Balances and Changes in Deferred Revenues Balances

The following table presents the deferred revenue balances (in thousands):

	As of July 31,		As of January 31,
	2021		2021
Deferred revenue, current	$	48,980	$	57,168
Deferred revenue, noncurrent		5,356		4,542
Total deferred revenue	$	54,336	$	61,710

Changes in the deferred revenue balances during the and six months ended July 31, 2021 and 2020 (unaudited) were as follows (in thousands):

	Six Months Ended July 31,
	2021			2020
Beginning balance	$	61,710		$	60,929
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year		(38,813	)		(39,997	)
Increases due to invoicing prior to satisfaction of performance obligations		31,439			26,483
Ending balance	$	54,336		$	47,415

Debt (Tables)

6 Months Ended

Jul. 31, 2021

Debt Disclosure [Abstract]

Schedule of Debt

Debt is presented net of issuance costs on the condensed consolidated balance sheets as follows (in thousands)

	As of July 31,			As of January 31,
	2021			2021
Principal outstanding	$	25,000		$	25,000
Unamortized discount and debt issuance costs		(37	)		(52	)
Long-term debt	$	24,963		$	24,948

Stockholders' Equity (Deficit) and Employee Incentive Plans (Tables)

6 Months Ended

Jul. 31, 2021

Equity And Compensation Related Costs Share Based Payments [Abstract]

Summary of Reserved Common Stock for Future Issuance

As of July 31, 2021, the Company has reserved common stock for future issuance, as follows:

	Number of Shares
Stock options outstanding		9,908,576
Common stock warrants		105,350
Reserved for future grant of stock options		4,120,000
Total		14,133,926

Summary of Stock Option Activity and Activity Regarding Shares Available for Grant under Stock Plans

Stock option activity and activity regarding shares available for grant under the Stock Plans for six months ended July 31, 2021 are as follows (aggregate intrinsic value in thousands):

				Options Outstanding
	Shares Available for Grant			Number of Options			Weighted- Average Exercise Price		Weighted- Average Contractual Term		Aggregate Intrinsic Value
Balances as of January 31, 2021		253,958			8,912,477		$	6.42		6.49	$	38,582
Additional shares reserved		5,604,548			—
Options exercised		—			(759,081	)	$	5.48
Options granted		(1,948,563	)		1,948,563		$	22.49
Options cancelled		210,057			(210,057	)	$	8.48
Balances as of July 31, 2021		4,120,000			9,891,902		$	9.61		6.94	$	203,235
Options vested and expected to vest as of July 31, 2021					9,891,902		$	9.61		6.94	$	203,235
Options vested and exercisable as of July 31, 2021					5,804,191		$	5.93		5.51	$	140,607

Summary of Fair Value of Employee Stock Options Estimated using Weighted-average Assumptions

The fair value of employee stock options was estimated using the following weighted-average assumptions:

	Three Months Ended July 31,						Six Months Ended July 31,
	2021			2020			2021			2020
Stock Option Plans:
Expected term (in years)		6.1			6.1			6.1			6.1
Expected volatility		42.4	%		39.9	%		42.0	%		39.9	%
Risk-free interest rate		1.0	%		0.4	%		1.0	%		0.4	%
Dividend yield		—			—			—			—

Summary of Stock-based Compensation Expense

Stock-based compensation expense was as follows (in thousands):

	Three Months Ended July 31,				Six Months Ended July 31,
	2021		2020		2021		2020
Cost of revenue—subscription	$	30	$	19	$	57	$	34
Cost of revenue—services		24		17		46		27
Research and development		569		394		1,139		640
Sales and marketing		688		412		1,229		676
General and administrative		670		524		1,339		830
Total stock-based compensation expense	$	1,981	$	1,366	$	3,810	$	2,207

Geographic Information (Tables)

6 Months Ended

Jul. 31, 2021

Segment Reporting [Abstract]

Schedule of Disaggregation of Revenue by Geographic Area

The following table depicts the disaggregation of revenue by geographic area based on the billing address of the customer (in thousands):

	Three Months Ended July 31,				Six Months Ended July 31,
	2021		2020		2021		2020
United States	$	18,336	$	16,149	$	36,383	$	31,366
International		11,363		9,011		21,271		16,839
Total	$	29,699	$	25,160	$	57,654	$	48,205

Net Loss per Share (Tables)

6 Months Ended

Jul. 31, 2021

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data):

	Three Months Ended July 31,						Six Months Ended July 31,
	2021			2020			2021			2020
Numerator
Net loss	$	(14,470	)	$	(8,838	)	$	(29,069	)	$	(20,188	)
Cumulative dividends on Series G redeemable convertible preferred stock		(1,438	)		(1,150	)		(2,917	)		(1,150	)
Net loss attributable to common stockholders	$	(15,908	)	$	(9,988	)	$	(31,986	)	$	(21,338	)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted		9,045			5,662			7,696			5,660
Net loss per share attributable to common stockholders, basic and diluted	$	(1.76	)	$	(1.76	)	$	(4.16	)	$	(3.77	)

Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share

	As of July 31,
	2021		2020
Stock options		9,909		9,194
Redeemable convertible preferred stock (on an if-converted basis)		—		26,312
Common stock warrants		105		105
Total		10,014		35,611

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended	6 Months Ended
	Jul. 26, 2021 shares	Jul. 31, 2021 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2021 USD ($)
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Proceeds from initial public offering, net of underwriting discounts and commissions \| $				$ 214,854
Deferred offering costs \| $		$ 2,100	$ 2,100	$ 2,100	$ 1,100
Fiscal year end date				--01-31
Common Stock
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Number of common stock for sale and issuance			9,589,999	9,589,999
Proceeds from initial public offering, net of underwriting discounts and commissions \| $		$ 214,900
Preferred stock converted into common stock		26,710,600	26,710,600	26,710,600
Reverse stock split of outstanding common stock				2.5
Initial Public Offering
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Deferred offering costs \| $		$ 4,900	$ 4,900	$ 4,900
Initial Public Offering \| Common Stock
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Number of common stock for sale and issuance		9,589,999
Common stock public offering price per share \| $ / shares		$ 24.00	$ 24.00	$ 24.00
Preferred stock converted into common stock	26,710,600
Underwriters Option to Purchase Additional Shares \| Common Stock
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]
Number of common stock for sale and issuance		1,250,869

Cash Equivalents and Short-Term Investments - Summary of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Cash Equivalents, Amortized Cost	$ 235,045	$ 31,438
Cash Equivalents, Estimated Fair Value	235,045	31,438
Short-Term Investments, Amortized Cost	14,322	19,545
Short-Term Investments, Gross Unrealized Gains		2
Short-Term Investments, Gross Unrealized Losses	(1)	(1)
Short-Term Investments, Estimated Fair Value	14,321	19,546
Cash Equivalents and Short-Term Investments, Amortized Cost	249,367	50,983
Cash Equivalents and Short-Term Investments, Estimated Fair Value	249,366	50,984
Commercial Paper
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Short-Term Investments, Amortized Cost	8,095	12,290
Short-Term Investments, Estimated Fair Value	8,095	12,290
Corporate Debt Securities
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Short-Term Investments, Amortized Cost	6,227	7,255
Short-Term Investments, Gross Unrealized Gains		2
Short-Term Investments, Gross Unrealized Losses	(1)	(1)
Short-Term Investments, Estimated Fair Value	6,226	7,256
Money Market Funds
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Cash Equivalents, Amortized Cost	235,045	31,438
Cash Equivalents, Estimated Fair Value	$ 235,045	$ 31,438

Cash Equivalents and Short Term Investments - Additional Information (Details)	3 Months Ended	6 Months Ended	12 Months Ended
	Jul. 31, 2021 USD ($) Investment	Jul. 31, 2021 USD ($) Investment	Jan. 31, 2021 USD ($) Investment
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Accumulated other comprehensive income (loss)	$ 0	$ 0	$ 1,000
Number of short-term investments in unrealized loss position \| Investment	5	5	1
Short-term investments estimated fair value	$ 4,400,000	$ 4,400,000	$ 900,000
Other than temporary impairment losses investments	$ 0	$ 0
Maximum
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]
Short term investments contractual maturity date		1 year	1 year

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

Fair Value Measurements - Fair Value Hierarchy For Company's Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	$ 14,321	$ 19,546
Fair Value, Measurements, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	235,045	31,438
Short-Term Investments, Estimated Fair Value	14,321	19,546
Total assets	249,366	50,984
Fair Value, Measurements, Recurring \| Commercial Paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	8,095	12,290
Fair Value, Measurements, Recurring \| Corporate Debt Securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	6,226	7,256
Fair Value, Measurements, Recurring \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	235,045	31,438
Total assets	235,045	31,438
Fair Value, Measurements, Recurring \| Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	14,321	19,546
Total assets	14,321	19,546
Fair Value, Measurements, Recurring \| Level 2 \| Commercial Paper
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	8,095	12,290
Fair Value, Measurements, Recurring \| Level 2 \| Corporate Debt Securities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Short-Term Investments, Estimated Fair Value	6,226	7,256
Fair Value, Measurements, Recurring \| Money Market Funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	235,045	31,438
Fair Value, Measurements, Recurring \| Money Market Funds \| Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash equivalents	$ 235,045	$ 31,438

Fair Value Measurements - Additional Information (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jul. 31, 2021	Jan. 31, 2021
Fair Value Disclosures [Abstract]
Fair value assets, Level 1 to Level 2 transfers, Amount	$ 0	$ 0
Fair value, assets, Level 2 to Level 1 transfers, Amount	0	0
Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset transfers into Level 3	0	0
Fair value, measurement with unobservable inputs reconciliation, recurring Basis, asset, transfers out of Level 3	$ 0	$ 0

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Prepaid expenses	$ 5,919	$ 803
Prepaid software	1,656	1,380
Other current assets	524	266
Total prepaid expenses and other current assets	$ 8,099	$ 2,449

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Property Plant And Equipment [Line Items]
Total gross property and equipment	$ 11,350	$ 10,871
Accumulated depreciation and amortization	(5,772)	(4,365)
Total property and equipment, net	5,578	6,506
Computer Equipment
Property Plant And Equipment [Line Items]
Total gross property and equipment	3,584	3,304
Furniture and Fixtures
Property Plant And Equipment [Line Items]
Total gross property and equipment	412	408
Capitalized Internal-Use Software
Property Plant And Equipment [Line Items]
Total gross property and equipment	5,772	5,772
Leasehold Improvements
Property Plant And Equipment [Line Items]
Total gross property and equipment	$ 1,582	$ 1,387

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Depreciation and amortization expense	$ 0.7	$ 0.4	$ 1.4	$ 0.6

Balance Sheet Components - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Accrued bonus	$ 4,182	$ 4,149
Accrued commissions	2,481	2,364
Accrued payroll and benefits	2,357	2,597
Total accrued compensation and benefits	$ 9,020	$ 9,110

Balance Sheet Components - Schedule of Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Accrued professional fees	$ 1,384	$ 1,925
Sales and value added tax payable	106	415
Income taxes payable	513	436
Accrued interest		95
Other	1,572	1,283
Total other accrued liabilities	$ 3,575	$ 4,154

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021	Jul. 31, 2020	Jan. 31, 2020
Revenue From Contract With Customer [Abstract]
Deferred revenue	$ 48,980	$ 57,168
Deferred revenue, noncurrent	5,356	4,542
Total deferred revenue	$ 54,336	$ 61,710	$ 47,415	$ 60,929

Deferred Revenue and Remaining Performance Obligations - Schedule of Changes In Deferred Revenue Balances (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Change In Contract With Customer, Liability [Roll Forward]
Beginning balance	$ 61,710	$ 60,929
Performance obligations satisfied during the period that were included in the deferred revenue balance at the beginning of the year	(38,813)	(39,997)
Increases due to invoicing prior to satisfaction of performance obligations	31,439	26,483
Ending balance	$ 54,336	$ 47,415

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) $ in Millions	Jul. 31, 2021 USD ($)
Revenue From Contract With Customer [Abstract]
Remaining performance obligation	$ 118.9

Deferred Revenue and Remaining Performance Obligations - Additional Information (Details) 1 $ in Millions	Jul. 31, 2021 USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 118.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-08-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligation	$ 74.1
Revenue expected to be recognized from remaining performance obligations, period	12 months

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Jan. 31, 2021
Debt Disclosure [Abstract]
Principal outstanding	$ 25,000	$ 25,000
Unamortized discount and debt issuance costs	(37)	(52)
Long-term debt	$ 24,963	$ 24,948

Debt - Additional Information (Details) - USD ($)	1 Months Ended						3 Months Ended		6 Months Ended
Debt - Additional Information (Details) - USD ($)	Jun. 30, 2021	Jan. 31, 2021	Apr. 30, 2019	Nov. 30, 2018	Aug. 31, 2018	Nov. 30, 2017	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Jan. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Interest expense, debt							$ 300,000	$ 2,500,000	$ 500,000	$ 4,000,000.0
Effective interest rate							3.90%	6.50%	3.90%	8.90%
Common Stock, par value		$ 0.00001					$ 0.00001		$ 0.00001
Borrowings		$ 25,000,000					$ 25,000,000		$ 25,000,000
Credit Facility
Debt Instrument [Line Items]
Line of credit facility adjusted quick ratio									1.15
Silicon Valley Bank \| Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 10,000,000.0
Line of credit facility maturity date		Jan. 31, 2024	Nov. 30, 2020	Nov. 30, 2019		Nov. 30, 2018
Line of credit facility, interest rate description									Borrowings under the line of credit bear interest at a floating per annum rate equal to one half of one percentage point (0.50%) above the prime rate, which interest shall be payable monthly.
Line of credit facility floating interest rate above prime rate						0.50%
Line of credit facility increase (decrease)		$ 40,000,000.0	$ (10,000,000.0)	$ 15,000,000.0
Line of credit facility current borrowing capacity			$ 0
Borrowed line of credit		$ 25,000,000.0
Fee payable on unused portion of line of credit		0.25%
Line of credit facility available for borrowing									$ 15,000,000.0
Silicon Valley Bank \| Credit Facility \| Prime Rate
Debt Instrument [Line Items]
Line of credit variable annual interest rate		0.50%
Warrant
Debt Instrument [Line Items]
Common Stock, par value			$ 7.48
Warrants exercisable period			10 years
Warrants aggregate percentage on borrowing amount			2.25%
Warrants issued to purchase common stock			75,250									30,100
Borrowings			$ 25,000,000.0									$ 10,000,000.0
Fair value of common stock			$ 400,000
Minimum \| Silicon Valley Bank \| Credit Facility
Debt Instrument [Line Items]
Line of credit facility termination fee		50.00%
Maximum \| Silicon Valley Bank \| Credit Facility
Debt Instrument [Line Items]
Line of credit facility termination fee		100.00%
Term Loan \| Hercules Capital
Debt Instrument [Line Items]
Effective interest rate			3.75%		10.75%
Maximum borrowing capacity	$ 70,000,000.0		$ 70,000,000.0		$ 35,000,000.0
Debt instrument, term					3 years
Debt instrument, maturity date					Sep. 30, 2021
Debt instrument, interest rate, increase (decrease)					(5.50%)
Net of issuance costs					$ 14,700,000						$ 34,800,000
Debt instrument, repayment date	Jun. 30, 2024		May 31, 2023
Debt instrument payment	$ 25,000,000.0
Current borrowing capacity	25,000,000.0
Prepayment penalty charges	400,000	$ 600,000
Prepayment end-of-term charges	$ 900,000	900,000
Loan outstanding amount paid including prepayment penalty and end of term charges		$ 25,000,000.0
Term Loan \| Hercules Capital \| Minimum
Debt Instrument [Line Items]
Penalty ranging of prepaid principal amount percentage					0.25%
Term Loan \| Hercules Capital \| Maximum
Debt Instrument [Line Items]
Penalty ranging of prepaid principal amount percentage					2.50%

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Jan. 31, 2021
Leases [Abstract]
Operating lease, rent expense	$ 700	$ 700	$ 1,300	$ 1,400
Operating lease expiration date			2025-03
Purchase commitment	10,000		$ 10,000
Purchase commitment, year one	3,000		3,000
Purchase commitment, year two	3,000		3,000
Purchase commitment, year three	4,000		4,000
Indemnification liability	$ 0		$ 0		$ 0

Retirement Plan - Additional Information (Details) - 401(K) [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Defined Contribution Plan Disclosure [Line Items]
Matching contributions	$ 100,000		$ 200,000	$ 200,000
Maximum
Defined Contribution Plan Disclosure [Line Items]
Matching contributions		$ 100,000

Stockholders' Equity (Deficit) and Employee Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Millions		1 Months Ended	3 Months Ended		6 Months Ended			12 Months Ended	26 Months Ended
	Jul. 26, 2021 $ / shares shares	Jul. 31, 2021 USD ($) Participant $ / shares shares	Jul. 31, 2021 USD ($) Participant $ / shares shares	Jul. 31, 2020 USD ($) $ / shares	Sep. 21, 2021 PurchasePeriod	Jul. 31, 2021 USD ($) Participant $ / shares shares	Jul. 31, 2020 USD ($) $ / shares	Jan. 31, 2021 USD ($) $ / shares shares	Sep. 20, 2023 PurchasePeriod
Class Of Stock [Line Items]
Redeemable convertible preferred stock, shares issued		0	0			0		26,070,213
Redeemable convertible preferred stock, shares outstanding		0	0			0		26,070,213
Redeemable convertible preferred stock, shares authorized		0	0			0		26,070,258
Redeemable convertible preferred stock , par value \| $ / shares		$ 0.00001	$ 0.00001			$ 0.00001		$ 0.00001
Common Stock, shares authorized		1,000,000,000	1,000,000,000			1,000,000,000		43,200,000
Common Stock, par value \| $ / shares		$ 0.00001	$ 0.00001			$ 0.00001		$ 0.00001
Common Stock, shares issued		43,282,941	43,282,941			43,282,941		6,199,305
Common Stock, shares outstanding		43,282,941	43,282,941			43,282,941		6,199,305
Common stock, voting rights						Each share of common stock is entitled to one vote.
Share-based compensation granted						1,948,563
Share-based compensation available for grant		4,120,000	4,120,000			4,120,000		253,958
Number of shares reserved common stock for future issuance		14,133,926	14,133,926			14,133,926
Option granted Weighted-average grant-date fair value \| $ / shares			$ 11.31	$ 2.99		$ 9.30	$ 2.99
Aggregate intrinsic value of options exercised \| $			$ 10.6			$ 14.4	$ 0.1
Unrecognized stock-based compensation expense related to unvested stock options \| $		$ 22.4	$ 22.4			$ 22.4		$ 8.7
Stock-based compensation expected to be recognized weighted-average period						2 years 9 months 18 days		2 years 6 months
Forecast
Class Of Stock [Line Items]
Initial offering period					The 2021 ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods.				The 2021 ESPP provides for 24-month offering periods beginning March 21 and September 21 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on July 22, 2021 and will end on September 20, 2023. The initial offering shall consist of four purchase periods with the first purchase period ending on March 20, 2022, and the final purchase period ending on September 20, 2023.
Initial offering period duration					24 months
Initial offering number of purchase periods \| PurchasePeriod					4				4
Maximum
Class Of Stock [Line Items]
Aggregate intrinsic value of options exercised \| $				$ 0.1
2021 Plan
Class Of Stock [Line Items]
Share-based compensation granted						0
Share-based compensation granted expiration period						10 years
Share-based compensation vesting period						4 years
Share-based compensation vesting rights						Options granted under the 2021 Plan expire ten years from the date of grant and generally vest over four years at a rate of 25% upon the first anniversary of the issuance date and 1/48 per month thereafter.
Share-based compensation available for grant		4,100,000	4,100,000			4,100,000
Number of shares reserved common stock for future issuance		4,120,000	4,120,000			4,120,000
Share-based compensation percentage of outstanding stock						5.00%
Share-based compensation future issuance description						The 2021 Plan provides that the number of shares reserved will automatically increase on the first day of each fiscal year, beginning on February 1, 2022, by an amount equal to the least of (i) 4,120,000 shares, (ii) five-percent (5%) of the outstanding Shares of our common stock on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the administrator of the 2021 Plan no later than the last day of the immediately preceding Fiscal Year.
2021 Plan \| First Anniversary
Class Of Stock [Line Items]
Share-based compensation vesting rights percentage						25.00%
Employee Stock Purchase Plan
Class Of Stock [Line Items]
Share-based compensation available for grant		830,000	830,000			830,000
Maximum percentage of employees contribute of base compensation to purchase shares of common stock		15.00%
Share base compensation to purchase shares of common stock price		85.00%
Number of participant may purchase more than 1000 shares \| Participant		0	0			0
Number of common stock issued		0
Common Stock
Class Of Stock [Line Items]
Redeemable convertible preferred stock converted into shares of common stock		26,710,600	26,710,600			26,710,600
Common Stock and Additional Paid-in-capital
Class Of Stock [Line Items]
Redeemable convertible preferred stock carrying amount \| $		$ 259.8	$ 259.8			$ 259.8
Initial Public Offering
Class Of Stock [Line Items]
Redeemable convertible preferred stock, shares authorized	200,000,000
Redeemable convertible preferred stock , par value \| $ / shares	$ 0.00001
Initial Public Offering \| Series E
Class Of Stock [Line Items]
Additional redeemable convertible preferred stock converted into shares of common stock	162,032
Initial Public Offering \| Series G
Class Of Stock [Line Items]
Additional redeemable convertible preferred stock converted into shares of common stock	478,355
Initial Public Offering \| Common Stock
Class Of Stock [Line Items]
Redeemable convertible preferred stock converted into shares of common stock	26,710,600
Additional redeemable convertible preferred stock converted into shares of common stock	640,387

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Reserved Common Stock for Future Issuance (Details)	Jul. 31, 2021 shares
Class Of Stock [Line Items]
Number of shares reserved common stock for future issuance	14,133,926
Warrant
Class Of Stock [Line Items]
Number of shares reserved common stock for future issuance	105,350
Stock Options Outstanding
Class Of Stock [Line Items]
Number of shares reserved common stock for future issuance	9,908,576
Reserved for Future Grant of Stock Options
Class Of Stock [Line Items]
Number of shares reserved common stock for future issuance	4,120,000

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock Option Activity and Activity Regarding Shares Available for Grant under Stock Plans (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) $ / shares shares
Equity And Compensation Related Costs Share Based Payments [Abstract]
Shares Available for Grant, Beginning balance	253,958
Additional shares reserved	5,604,548
Shares Available for Grant, Options granted	(1,948,563)
Shares Available for Grant, Options cancelled	210,057
Shares Available for Grant, Ending balance	4,120,000	253,958
Number of Options Outstanding, Beginning balance	8,912,477
Number of Options exercised	(759,081)
Number of Options granted	1,948,563
Number of Options cancelled	(210,057)
Number of Options Outstanding Ending Balance	9,891,902	8,912,477
Number of Options vested and expected to vest	9,891,902
Number of Options vested and exercisable as of July 31, 2021	5,804,191
Weighted-Average Exercise Price Options Outstanding, Beginning balance \| $ / shares	$ 6.42
Weighted-Average Exercise Price Options exercised \| $ / shares	5.48
Weighted-Average Exercise Price, Options granted \| $ / shares	22.49
Weighted-Average Exercise Price Options cancelled \| $ / shares	8.48
Weighted-Average Exercise Price Options Outstanding Ending Balance \| $ / shares	9.61	$ 6.42
Weighted-Average Exercise Price Options vested and expected to vest \| $ / shares	9.61
Weighted-Average Exercise Price Options vested and exercisable \| $ / shares	$ 5.93
Weighted-Average Contractual Term, Options balance	6 years 11 months 8 days	6 years 5 months 26 days
Weighted-Average Contractual Term, Options vested and expected to vest	6 years 11 months 8 days
Weighted-Average Contractual Term Options vested and exercisable	5 years 6 months 3 days
Aggregate Intrinsic Value Options Outstanding, Beginning balance \| $	$ 203,235	$ 38,582
Aggregate Intrinsic Value Options vested and expected to vest \| $	203,235
Aggregate Intrinsic Value Options vested and exercisable \| $	$ 140,607

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Fair Value of Employee Stock Options Estimated using Weighted-average Assumptions (Details)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Equity And Compensation Related Costs Share Based Payments [Abstract]
Expected term (in years)	6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days	6 years 1 month 6 days
Expected volatility	42.40%	39.90%	42.00%	39.90%
Risk-free interest rate	1.00%	0.40%	1.00%	0.40%

Stockholders' Equity (Deficit) and Employee Incentive Plans - Summary of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 1,981	$ 1,366	$ 3,810	$ 2,207
Research and Development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	569	394	1,139	640
Sales and Marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	688	412	1,229	676
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	670	524	1,339	830
Cost of Revenue -Subscription
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	30	19	57	34
Cost of Revenue - Services
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 24	$ 17	$ 46	$ 27

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 151	$ 254	$ 480	$ 482

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Geographic Information - Schedule of Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Segment Reporting Information [Line Items]
Total revenue	$ 29,699	$ 25,160	$ 57,654	$ 48,205
United States
Segment Reporting Information [Line Items]
Total revenue	18,336	16,149	36,383	31,366
International
Segment Reporting Information [Line Items]
Total revenue	$ 11,363	$ 9,011	$ 21,271	$ 16,839

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Geographic Information - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Customer Concentration Risk \| Revenue \| No Individual Foreign Country \| Maximum
Segment Reporting Information [Line Items]
Concentration risk, percentage	10.00%	10.00%	10.00%	10.00%

Net Loss per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Numerator
Net loss	$ (14,470)	$ (8,838)	$ (29,069)	$ (20,188)
Cumulative dividends on Series G redeemable convertible preferred stock	(1,438)	(1,150)	(2,917)	(1,150)
Net loss attributable to common stockholders	$ (15,908)	$ (9,988)	$ (31,986)	$ (21,338)
Denominator
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	9,045	5,662	7,696	5,660
Net loss per share attributable to common stockholders, basic and diluted	$ (1.76)	$ (1.76)	$ (4.16)	$ (3.77)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.

+ References + Details

Earnings Per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share	10,014	35,611
Stock options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share	9,909	9,194
Redeemable convertible preferred stock (on an if-converted basis)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share		26,312
Warrant
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Potentially dilutive securities were excluded from computation of diluted net loss per share	105	105

Subsequent Events - Additional Information (Details) $ in Millions	1 Months Ended
	Sep. 10, 2021 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Repayments of revolving line of credit	$ 25.0